Bartsch, Rupert https://orcid.org/0000-0002-4384-6917
Funding for this research was provided by:
Medical University of Vienna
Article History
Received: 8 September 2024
Accepted: 29 September 2024
First Online: 24 October 2024
Conflict of interest
: R. Bartsch reports the following conflicts of interest: Advisory Role: Astra-Zeneca, Daiichi, Eisai, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen, Stemline; Lecture Honoraria: Amgen, Astra-Zeneca, BMS, Celgene, Eli-Lilly, MSD, Novartis, Pfizer, Pierre-Fabre, Roche, Seagen, Stemline; Research Support: Daiichi, MSD, Novartis, Roche.